Clinical Trial Update: Safety and Efficacy Study of Lithium in Bipolar Disorder [Phase 3]

View source ↗

Summary

An update on a Phase 3 safety and efficacy study of lithium for Bipolar Disorder (Mania) by JDS Pharmaceuticals. The current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Mania

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: JDS Pharmaceuticals | Conditions: Bipolar Disorder, Mania | Phase 3 | Status: UNKNOWN